Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9NZ52: Variant p.Ser321Gly

ADP-ribosylation factor-binding protein GGA3
Gene: GGA3
Feedback?
Variant information Variant position: help 321 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Serine (S) to Glycine (G) at position 321 (S321G, p.Ser321Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 321 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 723 The length of the canonical sequence.
Location on the sequence: help VINGEVATLTLPDSEGNSQC S NQGTLIDLAELDTTNSLSSV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         VINGEVATLTLPDSEGNSQCSNQGTLIDLAELDTTNSLSSV

Mouse                         IVNGEVTTSTMPDSEGNSHCGNQGALIDLAELDAPSNSSPA

Rat                           IINGEVTTSTVPDSEGNSHCGNQGALIDLAELDTPSSSSPV

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 723 ADP-ribosylation factor-binding protein GGA3
Region 299 – 593 Unstructured hinge
Mutagenesis 313 – 313 D -> A. Acts as a dominant negative. Prevents proteolytic cleavage by CASP3; when associated with A-328, A-333 and A-428.
Mutagenesis 328 – 328 D -> A. Prevents proteolytic cleavage by CASP3; when associated with A-313, A-333 and A-428.
Mutagenesis 333 – 333 D -> A. Prevents proteolytic cleavage by CASP3; when associated with A-313, A-328 and A-428.



Literature citations
Joubert Syndrome in French Canadians and Identification of Mutations in CEP104.
Srour M.; Hamdan F.F.; McKnight D.; Davis E.; Mandel H.; Schwartzentruber J.; Martin B.; Patry L.; Nassif C.; Dionne-Laporte A.; Ospina L.H.; Lemyre E.; Massicotte C.; Laframboise R.; Maranda B.; Labuda D.; Decarie J.C.; Rypens F.; Goldsher D.; Fallet-Bianco C.; Soucy J.F.; Laberge A.M.; Maftei C.; Boycott K.; Brais B.; Boucher R.M.; Rouleau G.A.; Katsanis N.; Majewski J.; Elpeleg O.; Kukolich M.K.; Shalev S.; Michaud J.L.;
Am. J. Hum. Genet. 97:744-753(2015)
Cited for: VARIANTS ARG-132 AND GLY-321;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.